Soluble CD163: a marker molecule for monocyte/macrophage activity in disease
- 1 January 2002
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 62 (7) , 29-33
- https://doi.org/10.1080/003655102762377466
Abstract
By immunoprecipitation we have identified a soluble plasma form of CD163 (sCD163), the IL-6 inducible macrophage-receptor for clearing haptoglobinhaemoglobin complexes. A sandwich ELISA for measuring sCD163 was established and used to determine the sCD163 levels in normal subjects and patients with inflammatory and myeloproliferative diseases. In normal subjects, the concentration of sCD163 was high (median 1.9 mg/l) with low intraindividual variation. Highly increased levels were seen in patients with sepsis, myeloid leukaemia and in patients with Gaucher disease characterized by accumulation of tissue macrophages. Although the physiological role of sCD163 remains unknown, our present data suggest that sCD163 might prove to be a valuable marker molecule in infectious and myeloproliferative diseases.Keywords
This publication has 6 references indexed in Scilit:
- Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasmaBlood, 2002
- Soluble CD163 Inhibits Phorbol Ester-Induced Lymphocyte ProliferationBiochemical and Biophysical Research Communications, 2001
- Development of an ELISA to measure soluble CD163 in biological fluidsJournal of Immunological Methods, 2001
- Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuliJournal of Leukocyte Biology, 2000
- Genomic Organization and Chromosomal Localization of the Human CD163 (M130) Gene: A Member of the Scavenger Receptor Cysteine-Rich SuperfamilyBiochemical and Biophysical Research Communications, 1999
- Identification of the Integral Membrane Protein RM3/1 on Human Monocytes as a Glucocorticoid-Inducible Member of the Scavenger Receptor Cysteine-Rich Family (CD163)The Journal of Immunology, 1998